Vivo Bio Tech Stock Screener | Share Price & Fundamental Analysis
VIVOBIOT
Biotechnology
Screen Vivo Bio Tech share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price BSE
₹32.11
▲
0.57 (1.81%)
Market Cap
₹70.50 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
0.74
EPS (TTM)
₹4.76
Dividend Yield
-
Debt to Equity
0.96
52W High
₹51.79
52W Low
₹26.40
Operating Margin
41.00%
Profit Margin
8.33%
Revenue (TTM)
₹12.00
EBITDA
₹5.00
Net Income
₹1.00
Total Assets
₹143.00
Total Equity
₹78.00
Vivo Bio Tech Share Price History - Stock Screener Chart
Screen VIVOBIOT historical share price movements with interactive charts. Analyze price trends and patterns.
Vivo Bio Tech Company Profile - Fundamental Screener
Screen Vivo Bio Tech company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for VIVOBIOT shares.
Sector
Healthcare
Industry
Biotechnology
Sub-Sector
Biotechnology
Segment
E
ISIN
INE380K01017
Vivo Bio Tech Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen VIVOBIOT balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 143 | 137 | 123 | 123 | 80 | 64 | 55 | 60 | 51 | 46 |
| Current Assets | 42 | 47 | 32 | 26 | 27 | 27 | 25 | 28 | 20 | 22 |
| Fixed Assets | 88 | 80 | 89 | 95 | 52 | 35 | 30 | 28 | 29 | 24 |
| Liabilities | ||||||||||
| Total Liabilities | 143 | 137 | 123 | 123 | 80 | 64 | 55 | 60 | 51 | 46 |
| Current Liabilities | 38 | 45 | 46 | 52 | 15 | 10 | 9 | 15 | 22 | 15 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 78 | 54 | 52 | 47 | 43 | 33 | 27 | 19 | 13 | 10 |
| Share Capital | 17 | 15 | 15 | 14 | 13 | 13 | 12 | 10 | 9 | 9 |
| Reserves & Surplus | 54 | 40 | 37 | 32 | 28 | 20 | 15 | 7 | 3 | 1 |
Screen VIVOBIOT income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 12 | 13 | 13 | 12 | 10 | 17 | 12 | 15 | 12 | 9 | 13 | 15 | 11 | 13 | 14 |
| Expenses | 7 | 7 | 8 | 6 | 6 | 6 | 7 | 8 | 7 | 4 | 7 | 14 | 7 | 8 | 9 |
| EBITDA | 5 | 6 | 6 | 5 | 4 | 10 | 6 | 7 | 5 | 5 | 6 | 2 | 5 | 5 | 5 |
| Operating Profit % | 41.00% | 44.00% | 41.00% | 46.00% | 43.00% | 47.00% | 45.00% | 48.00% | 39.00% | 52.00% | 50.00% | 11.00% | 42.00% | 37.00% | 36.00% |
| Depreciation | 2 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Interest | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 2 | 2 | 2 |
| Profit Before Tax | 1 | 2 | 2 | 1 | 0 | 6 | 2 | 3 | 0 | 1 | 2 | -2 | 1 | 1 | 1 |
| Tax | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 1 | -1 | 0 | 0 | 0 |
| Net Profit | 1 | 1 | 1 | 1 | 0 | 5 | 1 | 2 | 0 | 0 | 1 | -1 | 0 | 0 | 0 |
| EPS | 0.69 | 0.74 | 0.45 | 0.50 | 0.11 | 3.51 | 0.55 | 1.38 | 0.10 | 0.22 | 0.89 | -0.49 | 0.22 | 0.08 | 0.10 |
Vivo Bio Tech Cash Flow Screener - Liquidity Fundamentals
Screen VIVOBIOT cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 12 | 16 | 15 | 17 | 14 | 9 | -1 | 11 | -6 | 9 |
| Investing Activities | -16 | -8 | -4 | -51 | -23 | -10 | -4 | -5 | -12 | -7 |
| Financing Activities | 4 | -8 | -11 | 35 | 9 | 2 | 1 | -3 | 7 | 0 |
| Net Cash Flow | 0 | 0 | 0 | 1 | 0 | 1 | -4 | 3 | -11 | 1 |
Screen VIVOBIOT shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Apr | 2025-May | 2025-Jun | 2025-Aug | 2025-Sept | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 40.85% | 43.36% | 42.29% | 39.06% | 36.43% | 35.16% | 42.08% | 42.08% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 34.74% | 33.27% | 35.48% | 34.39% | 33.48% | 32.30% | 25.35% | 26.11% |
| Other Holding | 24.41% | 23.37% | 22.23% | 26.55% | 30.09% | 32.53% | 32.57% | 31.81% |
| Shareholder Count | 21,169 | 21,935 | 21,909 | 21,896 | 21,890 | 21,659 | 18,971 | 18,852 |
Vivo Bio Tech Dividend Screener - Share Yield Analysis
Screen VIVOBIOT dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Vivo Bio Tech Index Membership - Market Screener Classification
Screen VIVOBIOT by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Vivo Bio Tech Market Events Screener - Corporate Actions
Screen VIVOBIOT market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -1.59% | ||
| Annual General Meeting | NA | 0.96% | ||
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | 1.46% |
| 2025-08-12 | 2025-08-12 | Quarterly Result Announcement | NA | 13.72% |
| 2025-05-19 | 2025-05-19 | Quarterly Result Announcement | NA | 3.47% |
| 2025-02-07 | 2025-02-07 | Extraordinary General Meeting | NA | -8.43% |
| 2025-01-09 | 2025-01-09 | Quarterly Result Announcement | NA | 27.98% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -5.94% |
Vivo Bio Tech Competitors Screener - Peer Comparison
Screen VIVOBIOT competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Anthem Biosciences | 36,755 | 69.53 | 1,930 | 30.15% | 451 | 46.67 |
| Advanced Enzyme Tech | 3,382 | 22.55 | 670 | 1.44% | 134 | 45.76 |
| Genesis IBRC | 105 | -471.56 | 4 | % | 0 | 20.74 |
| Vivo Bio Tech | 71 | 17.24 | 52 | 13.19% | 7 | 54.91 |
| Shree Ganesh Bio-Tech | 25 | 24 | 14.55% | 0 | 49.45 | |
| Genomic Valley Biotech | 8 | 77.97 | 1 | 300.00% | 0 | 51.33 |
Vivo Bio Tech Company Announcements - News Screener
Screen VIVOBIOT latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-03 | Closure of Trading Window | View |
| 2025-12-08 | Report On Publicity For Re-Lodgement Of Transfer Requests Of Physical Shares | View |
| 2025-11-17 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-14 | Board Meeting Outcome for Board Meeting Convened On November 14 2025. | View |
| 2025-11-14 | Un-Audited Standalone & Consolidated Financial Results For The Quarter And Half-Year Ended September 30 2025 | View |
| 2025-11-05 | Report On Publicity For Re-Lodgement Of Transfer Requests Of Physical Shares | View |
| 2025-11-04 | Board Meeting Intimation for Meeting Scheduled To Be Held On Friday November 14 2025. | View |
| 2025-10-09 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-10-07 | Report On Publicity For Re-Lodgement Of Transfer Requests Of Physical Shares | View |
| 2025-10-01 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-09-30 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-25 | Closure of Trading Window | View |
| 2025-09-24 | Announcement under Regulation 30 (LODR)-Allotment | View |
| 2025-09-23 | Report On Publicity For Re-Lodgement Of Transfer Requests Of Physical Shares | View |
| 2025-09-15 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-09-08 | Reg. 34 (1) Annual Report. | View |
| 2025-09-08 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-09-06 | Annual Report Along With Notice Of 38Th Annual General Meeting (AGM) | View |
| 2025-09-06 | Notice Of 38Th Annual General Meeting (AGM) | View |
| 2025-09-04 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |